O4 Detail Hero Banner

Formulary drug lists

Optum Rx helps minimize patient disruption during formulary cycle updates and throughout the year.  Use the lists below to find coverage information.

O4 2 Columns (3/4 - 1/4)
O4 1 Column (Full)
O4 Text Component

Pharmacy Passages

Pharmacy Passages is an Optum Rx publication listing monthly updates to our standard formularies. For updates specific to health plans and custom drug lists, please check with the member's prescription benefit plan.

O4 Accordion
February 2024 IssueDownload
January 2024 IssueDownload
December 2023 IssueDownload
November 2023 IssueDownload
October 2023 IssueDownload
September 2023 IssueDownload
February 2024 IssueDownload
January 2024 IssueDownload
December 2023 IssueDownload
November 2023 IssueDownload
October 2023 IssueDownload
September 2023 IssueDownload
O4 1 Column (Full)
O4 Text Component

Formulary & UM updates

These updates may include exclusions, tier changes, prior authorizations, quantity limits and/or step therapy.

O4 Accordion

January 1, 2024 updates

O4 Accordion

July 1, 2023 updates

O4 1 Column (Full)
O4 Text Component

Supporting your patients

During formulary cycle updates, Optum Rx reaches out to impacted patients with the information they need, including suggested covered alternative medications. We’re here to support you and your patients through this process.

Here are a few things you can do to help make the transition smoother for your patients:

  • Reach out to your patient
    Or they may be contacting you with questions.
  • Discuss their options
    Determine if other covered medications could benefit the patient.
  • Select the medication
    If alternative medication is selected, send us an e-prescription. (Send CancelRx for the affected medication.)
  • Sticking with their current medication?
    A prior authorization may be required. Visit go.covermymeds.com/optumrx to submit.
O4 1 Column (Full)
O4 Text Component

Certain states require Optum Rx to communicate prior authorization changes before the effective date. Flyers are sent to members to outline the drugs affected by prior authorization, quantity limits, and step therapy based on benefit plan designs. Please review each document for more details.

Please note: these changes may not reflect final P&T Committee determinations. These changes are specific to prescription drug benefits only, and do not reflect changes that may occur at the health plan level. Prescribers are strongly encouraged to check with the health plan for other changes that may occur.